Cancer Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Ascites
Research from Catholic University, Department of Laboratory Medicine provide new insights into ascites
August 2nd, 2008
Researchers detail in 'Vascular endothelial growth factor levels in ascites between chemonaive and chemotreated patients,' new data in ascites. According to a study from Korea, "Vascular endothelial growth factor (VEGF) levels in malignant ascites have high diagnostic value for their discrimination from ascites of non-malignant origin. However, there have been no reports on the comparison of VEGF levels between malignant ascites of chemonaive and chemotreated patients." "VEGF levels were measured in 44 ascites patients (cirrhosis ascites, 10; chemonaive patients, 21; chemotreated patients, 13) and compared to the level of carcinoembryonic antigen (CEA) and carbohydrate...
Source: Cancer Law Weekly (2008-08-02)
|
